Skip to main content

Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men

Cancer Causes & Control volume 8, pages 615–625 (1997)Cite this article

Abstract

Experimental and human epidemiologic data suggest a protective rolefor vitamin D in large bowel cancer. To investigate this association, weconducted a nested case-control study within a Finnish clinical trial cohort.Cases (n = 146) were participants diagnosed with primary adenocarcinoma ofthe large bowel. Controls were matched (2:1) to cases on age, date ofbaseline blood draw, and study clinic. Prediagnostic serum levels of thevitamin D metabolites, 25-hydroxyvitamin D (25-OH D), and1,25-dihydroxyvitamin D (1,25-DIOHD) were used as primary exposure measures.The baseline geometric-mean serum level of 25-OH D was 11.6 percent lower incases than in controls (12.2 cf 13.8 ug/l, P = 0.01) while serum levels of1,25-DIOH D did not differ by case-control status. No association was seenbetween serum levels of 1,25-DIOH D and large bowel cancer risk. However, theestimated relative risk (RR) of large bowel cancer decreased with increasinglevel of serum 25-OH D and the associa tion was more pronounced for rectalcancer (55 cases; RR by quartile = 1.00, 0.93, 0.77, 0.37; trend P = 0.06).Neither exclusion of early cases nor multivariate adjustment for potentialconfounders materially altered these estimates. There was no evidence ofeffect modification by level of 1,25-dihydroxyvitamin D or with other knownrisk-factors for large bowel cancer.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price includes VAT (USA)
Tax calculation will be finalised during checkout.

References

  1. American Cancer Society. Cancer Facts and Figures-1994. Atlanta, GA (USA): ACS, 1994.

    Google Scholar 

  2. Miller BA, Gloeckler-Ries LA, Hankey BF, et al. SEER Cancer Statistics Review: 1973-1990. Bethesda, MD (USA): National Cancer Institute, 1993.

    Google Scholar 

  3. Hakulinen T, Kenward M, Luostarinen T, et al. Cancer in Finland in 1954-2008: incidence, mortality and prevalence by region. Helsinki: Finnish Foundation for Cancer Research, 1989.

    Google Scholar 

  4. Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol {dy1980}; 9: 227–31.

    Google Scholar 

  5. Gorham ED, Garland CF, Garland FC. Acid haze air pollution and breast and colon cancer mortality in 20 Canadian cities. Can J Public Health {dy1989}; 80: 96–100.

    Google Scholar 

  6. Emerson JC, Weiss NS. Colorectal cancer and solar radiation. Cancer Causes Control {dy1992}; 3: 95–9.

    Google Scholar 

  7. Garland CF, Shekelle RB, Barrett-Connor E, Criqui MH, Rossof AH, Paul O. Dietary vitamin D and calcium and risk of colorectal cancer: a 19 year prospective study in men. Lancet {dy1985}; 1: 307–9.

    Google Scholar 

  8. Bostick RM, Potter JD, Sellers TA, McKenzie DR, Kushi LH, Folsom AR. Relation of calcium, vitamin D, and dairy food intake to incidence of colon cancer among older women. Am J Epidemiol {dy1993}; 137: 1302–17.

    Google Scholar 

  9. Garland CF, Garland FC, Ko Shaw E, Gorham ED, Comstock GW, Helsing KJ. Serum 25-hydroxyvitamin D and colon cancer: eight year prospective study. Lancet {dy1989}; 2: 1176–8.

    Google Scholar 

  10. Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW. Colon cancer and prediagnostic serum 25-D and 1,25-D levels [Abstract]. In: Norman AW, Bouillon R, Thomasset M, eds. Vitamin D. A Pluripotent Steroid Hormone: Structural Studies, Molecular Endocrinology, and Clinical Applications. Berlin, Germany: de Gruyter, 1994: 494–5.

    Google Scholar 

  11. Garland CF, Garland FC, Gorham ED. Can colon cancer incidence and death rates be reduced with calcium and vitamin D? Am J Clin Nutr {dy1991}; 54: 193s–201s.

    Google Scholar 

  12. Garland CF, Garland FC, Gorham ED. Colon cancer parallels rickets. In: Lipkin M, Newmark HL, Kelloff G, eds. Calcium, Vitamin D and Prevention of Colon Cancer. Boca Raton, Fl (USA): CRC Press, 1991: 81–108.

    Google Scholar 

  13. Ross TK, Darwish HM, DeLuca HF. Molecular biology of vitamin D action. Vitam Horm {dy1994}; 49: 281–326.

    Google Scholar 

  14. Haussler MR, McCain TA. Basic and clinical concepts related to vitamin D metabolism and action. NEJM {dy1977}; 297: 974–83.

    Google Scholar 

  15. Reichel H, Koeffler HP, Norman AW. The role of the vitamin D endocrine system in health and disease. NEJM {dy1989}; 320: 980–91.

    Google Scholar 

  16. DeLuca HF. Vitamin D Metabolism and Function. New York,NY (USA): Springer-Verlag, 1979.

    Google Scholar 

  17. Fraser DR. Vitamin D. Lancet {dy1995}; 345: 104–7.

    Google Scholar 

  18. Darwish H, DeLuca HF. Vitamin D-regulated gene expression. Crit Rev Eukar Gene Express {dy1993}; 3: 89–116.

    Google Scholar 

  19. Abe E, Miyaura H, Sakagami M, et al. Differentiation of mouse myeloid leukemia cells induced by 1, alpha-25-dihydroxyvitamin D3. Proc Natl Acad Sci {dy1981}; 78: 4990–4.

    Google Scholar 

  20. Colston KW, Colston MJ, Feldman D. 1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology {dy1981}; 108: 1083–6.

    Google Scholar 

  21. Frampton RJ, Suva LJ, Eisman JA, et al. Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture. Cancer Res {dy1982}; 42: 1116–9.

    Google Scholar 

  22. Lointier P, Wargovich MJ, Saez S, Levin B, Wildrick DM, Boman BM. The role of vitamin D3 in the proliferation of a human colon cancer cell line in vitro. Anticancer Res {dy1987}; 7: 817–22.

    Google Scholar 

  23. Brehier A, Thomasset M. Human colon cell line HT-29: characterization of the 1,25-dihydroxyvitamin D3 receptor and induction of differentiation by the hormone. J Steroid Biochem {dy1988}; 29: 265–70.

    Google Scholar 

  24. Harper KD, Iozzo RV, Haddad JG. Receptors for and bioresponses to 1,25-dihydroxyvitaminDin a human colon carcinoma cell line. Metabolism {dy1989}; 38: 1062–9.

    Google Scholar 

  25. Cross HS, Huber C, Peterlik M. Antiproliferative effect of 1,25-dihydroxyvitamin D3 and its analogs on human colon adenocarinoma cells (CACO-2): influence of extracellular calcium. Biochem Biophys Res Commun {dy1991}; 179: 57–62.

    Google Scholar 

  26. Thomas MG, Tebbutt S, Williamson RCN. Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line. Gut {dy1992}; 33: 1660–3.

    Google Scholar 

  27. Shabahang M, Buras RR, Davoodi F, Schumaker LM, Nauta RJ, Evans SR. 1,25-dihydroxyvitamin D3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition. Cancer Res {dy1993}; 53: 3712–8.

    Google Scholar 

  28. Pence BC, Buddingh F. Inhibition of dietary fat-promoted colon carcinogenesis in rats by supplemental calcium or vitamin D3. Carcinogenesis {dy1988}; 9: 187–90.

    Google Scholar 

  29. Sitrin MD, Halline AG, Abrahams C, Brasitus TA. Dietary calcium and vitamin D modulate 1,2-dimethylhydrazineinduced colonic carcinogenesis in the rat [Abstract]. Cancer Res {dy1991}; 51: 5608–13.

    Google Scholar 

  30. Beaty MM, Lee EY, Glauert HP. Influence of dietary calcium and vitamin D on colon epithelial cell proliferation and 1,2-dimethylhydrazine-induced colon carcinogenesis in rats fed high fat diets [Abstract]. J Nutr {dy1993}; 123: 144–52.

    Google Scholar 

  31. Batchelor AJ, Compston JE. Reduced plasma half-life of radio-labelled 25-hydroxyvitamin D3 in subjects receiving a high-fibre diet. Br J Nutr {dy1983}; 49: 213–6.

    Google Scholar 

  32. Punnonen R, Gillespy M, Hahl M, Koskinen T, Notelovitz M. Serum 25-OHD, Vitamin A and vitamin E concentrations in healthy Finnish and Floridian women. Int J Vit Nutr Res {dy1987}; 58: 37–9.

    Google Scholar 

  33. Holick MF. Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr {dy1995}; 61(Suppl.): 638s–45s.

    Google Scholar 

  34. Lamberg-Allardt C. Vitamin D intake, sunlight exposure and 25-hydroxyvitamin D levels in the elderly during one year. Ann Nutr Metab {dy1984}; 28: 144–50.

    Google Scholar 

  35. Beadle PC, Burton JL, Leach JF. Correlation of seasonal variation of 25-hydroxycholecalciferol with UV radiation dose. Br J Dermatol {dy1980}; 103: 289–93.

    Google Scholar 

  36. Holmberg I, Larsson A. Seasonal variation of vitamin D3 and 25-hydroxyvitamin D3 in human serum. Clin Chim Acta {dy1980}; 100: 173–4.

    Google Scholar 

  37. Sowers JR, Wallace RB, Hollis BW, Lemke JH. Parameters related to 25-OH-D levels in a population-based study of women. Am J Clin Nutr {dy1986}; 43: 621–8.

    Google Scholar 

  38. Holick MF. The use and interpretation of assays for vitamin D and its metabolites. J Nutr {dy1990}; 120: 1464–9.

    Google Scholar 

  39. The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group. The alpha-tocopherol, beta carotene lung cancer prevention trial: design, methods, participant characteristics, and compliance. Ann Epidemiol {dy1994}; 4: 1–9.

    Google Scholar 

  40. The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. NEJM {dy1994}; 330: 1029–35.

    Google Scholar 

  41. World Health Organization. International Classification of Diseases, Ninth Revision. Geneva, Switzerland: WHO, 1997.

    Google Scholar 

  42. Kyllonen LEJ, Teppo L, Lehtonen M. Completeness and accuracy of registration of colorectal cancer in Finland. Ann Chir Gynaecol {dy1987}; 76: 185–90.

    Google Scholar 

  43. Pearce N. Incidence density matching with a simple SAS computer program. Int J Epidemiol {dy1989}; 18: 981–4.

    Google Scholar 

  44. Hollis BW, Kamerud JQ, Selvaag SR, Lorenz JD, Napoli JL. Determination of vitamin D status by radioimmuno assay with an125I-labeled tracer. Clin Chem {dy1993}; 39: 529–33.

    Google Scholar 

  45. Hollis BW. Assay of circulating 1,25-dihydroxyvitamin D involving a novel single-cartridge extraction and purification procedure. Clin Chem {dy1986}; 32: 2060–3.

    Google Scholar 

  46. Pietinen P, Hartman AM, Haapa E, et al. Reproducibility and validity of dietary assessment instruments: 1. A selfadministered food use questionnaire with a portion size booklet. Am J Epidemiol {dy1988}; 128: 655–66.

    Google Scholar 

  47. Devesa SS, Chow WH. Variation in colorectal cancer incidence in the United States by subsite of origin. Cancer {dy1993}; 71: 3819–26.

    Google Scholar 

  48. Delattre O, Olschwang S, Law DJ, et al. Multiple genetic alterations in distal and proximal colorectal cancer. Lancet {dy1989}; 2: 353–6.

    Google Scholar 

  49. Stewart RJ, Stewart AW, Turnbull PRG, Isbister WH. Sex differences in subsite incidence of large bowel cancer. Dis Colon Rectum {dy1983}; 26: 658–60.

    Google Scholar 

  50. Bufill J. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med {dy1990}; 113: 779–88.

    Google Scholar 

  51. Offerhaus GJA, Giardiello FM, Tersmette KWF, et al. Ethnic differences in the anatomical location of colorectal adenomatous polyps. Int J Cancer {dy1991}; 49: 641–4.

    Google Scholar 

  52. Ponz de Leon M, Sachhetti C, Sassatelli R, Zanghieri G, Roncucci L, Scalmati A. Evidence for the existence of different types of large bowel tumor: suggestions from the clinical data of a population-based registry. J Surg Oncol {dy1990}; 44: 35–43.

    Google Scholar 

  53. Faivre J, Bedenne L, Boutron MC, Milan C, Collonges R, Arveux P. Epidemiological evidence for distinguishing subsites of colorectal cancer. J Epidemiol Community Health {dy1989}; 43: 356–61.

    Google Scholar 

  54. Launoy G, Pottier D, Gignoux M.Cancer du colon proximal et cancer du colon distal: deux cancers epidemiologiquement differents. Gastroenterol Clin Biol {dy1989}; 13: 255–259.

    Google Scholar 

  55. Beart RW, Melton LJ, Maruta M, Dockerty MB, Frydenberg HB, O'Fallon WM. Trends in right and left-sided colon cancer. Dis Colon Rectum {dy1983}; 26: 393–8.

    Google Scholar 

  56. West DW, Slattery ML, Robison LM, et al. Dietary intake and colon cancer: sex and anatomic site-specific associations. Am J Epidemiol {dy1989}; 130: 883–94.

    Google Scholar 

  57. Pocard M, Salmon RJ, Muleris M, et al. Deux colon-deux cancers? Adenocarcinomes coliques proximal ou distal: arguments en faveur d'une cancerogenese distincte. Bull Cancer {dy1995}; 82: 10–21.

    Google Scholar 

  58. SAS Institute, Inc. SAS/STAT Software: the PHREG Procedure, Version 6. Cary, NC (USA): SAS Institute, Inc., 1991; SAS Technical Report P-217.

    Google Scholar 

  59. SAS Institute, Inc. SAS/STAT User's Guide, Version 6. 4th Edition. Cary, NC (USA): SAS Institute, Inc., 1989.

    Google Scholar 

  60. Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW. Colon cancer and serum vitamin D metabolite levels 10-17 years prior to diagnosis. Am J Epidemiol {dy1995}; 142: 608–11.

    Google Scholar 

  61. Cugini P, Coen G, Scavo D, et al. Circannual versus seasonal variation of longitudinally sampled 25-hydroxycholecalciferol serum levels. Biochem Med {dy1984}; 32: 22–9.

    Google Scholar 

  62. Hollis BW. Assessment of vitamin D nutritional and hormonal status: what to measure and how to do it. Calcif Tissue Int {dy1996}; 58: 4–5.

    Google Scholar 

  63. Tsang RC, Cruz M, Specker B. Vitamin D in infancy: 25-hydroxyvitamin D, an important bioactive principle in vivo in infancy? In: Norman AW, Bouillon R, Thomasset M, eds. Vitamin D, Gene Regulation, Structure-function Analysis and Clinical Application. Berlin, Germany: de Gruyter, 1991: 739–44.

    Google Scholar 

  64. Bell NH, Epstein S, Greene A, Shary J, Oexmann MJ, Shaw S. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest {dy1985}; 76: 370–3.

    Google Scholar 

  65. Barger-Lux MJ, Heaney RP, Lanspa SJ, Healy JC, DeLuca HF. An investigation of sources of variation in calcium absorption efficiency. J Clin Endocrinol Metab {dy1995}; 80: 406–11.

    Google Scholar 

  66. Bell NH. 25-hydroxyvitamin D3 reverses alteration of the vitamin D-endocrine system in blacks. Am J Med {dy1995}; 99: 597–9.

    Google Scholar 

  67. Corder EH, Guess HA, Hulka BS, et al. Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol Biomark Prev {dy1993}; 2: 467–72.

    Google Scholar 

  68. Corder EH, Friedman GD, Vogelman JH, Orentreich N. Seasonal variation in vitamin D, vitamin D-binding protein and dehydroepiandrosterone: risk of prostate cancer in black and white men. Cancer Epidemiol Biomark Prev {dy1995}; 4: 655–9.

    Google Scholar 

  69. Mawer EB, Hayes ME, Heys SE, et al. Constitutive synthesis of 1,25-dihydroxyvitamin D3 by a human small cell lung cancer cell line. J Clin Endocrinol Metab {dy1994}; 79: 554–60.

    Google Scholar 

  70. Reitsma PH, Rothberg PG, Astrin SM, et al. Regulation of c-myc gene expression in HL-60 leukemia cells by a vitamin D metabolite. Nature {dy1983}; 306: 492–6.

    Google Scholar 

  71. Matsui T, Takahashi R, Mihara K, et al. Cooperative regulation of c-myc expression in differentiation of human promyelocytic leukemia induced by recombinant gamma-interferon and 1,25-dihydroxyvitamin D3. Cancer Res {dy1985}; 45: 4366–71.

    Google Scholar 

  72. Manolagas SC, Provedini DM, Murray EJ, Murray SS, Tsonis PA, Spandidos DA. Association between the expression of the c-myc oncogene mRNA and the expression of the receptor protein for 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci {dy1987}; 84: 856–60.

    Google Scholar 

  73. Brelvi ZS, Studzinski GP. Inhibition of DNA synthesis by an inducer of differentiation of leukemic cells, 1 alpha, 25-dihydroxyvitamin D3, precedes down regulation of the c-myc gene. J Cell Physiol {dy1986}; 128: 171–9.

    Google Scholar 

  74. Eisman JA, Koga M, Sutherland RL, Barkla DH, Tutton PJM. 1,25-dihydroxyvitamin D3 and the regulation of human cancer cell replication. Proc Soc Exp Biol Med {dy1989}; 191: 221–6.

    Google Scholar 

  75. Vandewalle B, Wattez N, Lefebvre J. Effects of vitamin D3 derivatives on growth, differentiation and apoptosis in tumoral colonic HT 29 cells: possible implication of intracellular calcium. Cancer Lett {dy1995}; 97: 99–106.

    Google Scholar 

  76. Lointier P, Meggouh F, Pezet D, et al. Specific receptors for 1,25-dihydroxyvitamin D3 and human colorectal carcinogenesis. Anticancer Res {dy1989}; 9: 1921–4.

    Google Scholar 

  77. Meggouh F, Lointier P, Saez S. Sex steroid and 1,25-dihydroxyvitamin D3 receptors in human colorectal adenocarcinoma and normalmucosa. Cancer Res {dy1991}; 51: 1227–33.

    Google Scholar 

  78. Lointier P, Meggouh F, Dechelotte P, et al. 1,25-dihydroxyvitamin D3 receptors and human colon adenocarcinoma. Br J Surg {dy1991}; 78: 435–9.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Cancer Institute, NIH, Bethesda, USA

    Joseph Tangrea, Philip Taylor, Jarmo Virtamo & Demetrius Albanes

  2. School of Hygiene and Public Health, Johns Hopkins Universitycty, Baltimore, USA

    Kathy Helzlsouer

  3. National Public Health Institute, Helsinki, USA

    Pirjo Pietinen

  4. Medical University of South Carolina, Charleston, USA

    Bruce Hollis

Authors
  1. Joseph Tangrea
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kathy Helzlsouer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pirjo Pietinen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Philip Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bruce Hollis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jarmo Virtamo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Demetrius Albanes
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Tangrea, J., Helzlsouer, K., Pietinen, P. et al. Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control 8, 615–625 (1997). https://doi.org/10.1023/A:1018450531136

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018450531136

  • 25-hydroxyvitamin D
  • colorectal cancer
  • Finland
  • men
  • rectal cancer
  • vitamin D